comparemela.com

Latest Breaking News On - Unity biotechnology inc - Page 14 : comparemela.com

Unity Biotechnology, Inc (NASDAQ:UBX) Short Interest Down 35 5% in May

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totalling 448,000 shares, a drop of 35.5% from the April 30th total of 694,600 shares. Based on an average daily trading volume, of 534,800 shares, the days-to-cover ratio […]

The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More

Longevity and Anti-senescence Therapy Market to Reach $44 2 Bn, Globally, by 2030 at 6 1% CAGR: Allied Market Research

Rise in prevalence of chronic diseases, surge in awareness about anti-aging products, and advancements in AI-driven medical technology drive the growth of the global longevity and anti-senescence

Retro Biosciences raises $180M, aims to add 10 years of lifespan - San Francisco Business Times

Retro Biosciences raises $180M, aims to add 10 years of lifespan - San Francisco Business Times
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

Unity Biotechnology, Inc (NASDAQ:UBX) Receives Consensus Recommendation of Buy from Analysts

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) has been given a consensus recommendation of “Buy” by the seven brokerages that are covering the company, MarketBeat.com reports. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month target price among brokerages that […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.